Asthma, Pulmonary Disease, Chronic Obstructive
Conditions
Keywords
Medication Adherence, Patient Compliance
Brief summary
The purpose of this trial is to discover whether providing feedback to patients from a device that records when and how well a patient uses a Seretide Diskus inhaler will lead to: * Improved compliance with prescribed inhaler use * Improved technique of inhaler use * A reduction in respiratory health related outcomes caused by poor inhaler compliance and usage. * An improvement in patient quality of life scores
Interventions
DEVICEFeedback
Feedback on the patient's own inhaler use, with personalized information on the patients technique and timing of use of the diskus inhaler as recorded on the INCA device will be provided to patients in the feedback group after 1,2 and 6 months.
BEHAVIORALEducation
Feedback on the patient's own inhaler technique as observed by pharmacist and education to support best use will be provided to patients in the demonstration group after 1,2 and 6 months.
Sponsors
Royal College of Surgeons, Ireland
Beaumont Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Must be 18 years old or above * Capable of understanding and willing to provide voluntary informed consent before any protocol specific procedures are performed * Capable of understanding and complying with the requirements of the protocol, and demonstrating a willingness to attend for all required visits. * Able and willing to take inhaled medication. * Have a valid prescription for use of a Seretide diskus inhaler or already using a Seretide diskus inhaler. * Have a history of regular attendance in the pharmacy in which they are recruited which will be demonstrated by the subject having collected three prescriptions for any medication in that pharmacy in the six months preceeding their recruitment to the study.
Exclusion criteria
* Patient expressly reports that their physician has indicated that they will not be continuing to receive Seretide over the next 6 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rate of adherence | 2 months and 6 months | The rate of adherence is the proportion of correctly taken drugs at the correct time relative to the prescribed interval. |
Secondary
| Measure | Time frame |
|---|---|
| Rescue inhaled medication use | Six months |
| Rescue antibiotic and/or steroid medication use | 6 months |
| Quality of life | 2 months and 6 months |
| Adherence in the time domain | Two months and six months |
| Technique adherence | Two months and six months |
Countries
Ireland
Outcome results
None listed